Royce & Associates LP lessened its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 21.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 946,623 shares of the construction company's stock after selling 265,474 shares during the quarter. Royce & Associates LP owned 1.15% of Aspen Aerogels worth $11,246,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently bought and sold shares of ASPN. Abbot Financial Management Inc. raised its holdings in shares of Aspen Aerogels by 3.9% in the 4th quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company's stock worth $359,000 after purchasing an additional 1,146 shares during the period. Franklin Resources Inc. raised its stake in shares of Aspen Aerogels by 5.3% in the third quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company's stock valued at $815,000 after buying an additional 1,483 shares during the period. Greenwood Capital Associates LLC raised its stake in shares of Aspen Aerogels by 5.0% in the fourth quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company's stock valued at $439,000 after buying an additional 1,749 shares during the period. Swiss National Bank lifted its position in shares of Aspen Aerogels by 1.9% during the 4th quarter. Swiss National Bank now owns 128,800 shares of the construction company's stock valued at $1,530,000 after buying an additional 2,400 shares during the last quarter. Finally, Rhumbline Advisers boosted its position in Aspen Aerogels by 2.8% during the fourth quarter. Rhumbline Advisers now owns 93,044 shares of the construction company's stock worth $1,105,000 after purchasing an additional 2,554 shares during the period. Institutional investors own 97.64% of the company's stock.
Aspen Aerogels Price Performance
ASPN traded up $0.13 on Friday, reaching $7.06. The company had a trading volume of 1,495,446 shares, compared to its average volume of 1,791,227. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels, Inc. has a 52-week low of $6.62 and a 52-week high of $33.15. The company has a market cap of $578.93 million, a price-to-earnings ratio of 44.10 and a beta of 2.28. The business has a 50 day simple moving average of $9.72 and a 200 day simple moving average of $15.55.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, sell-side analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on ASPN shares. Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Craig Hallum dropped their target price on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. B. Riley reduced their price target on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a research report on Wednesday, February 19th. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a research note on Wednesday, February 19th. Finally, Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $19.11.
View Our Latest Report on Aspen Aerogels
Aspen Aerogels Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Articles

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.